Pathfinders in oncology from the first clinical use of single‐agent chemotherapy to the introduction of mammography
During the period from 1942 to 1962, treatment attempts with single‐agent chemotherapy such as nitrogen mustard and urethan gained limited application. However, the groundbreaking success with aminopterin in the treatment of patients with pediatric acute leukemia and methotrexate in the treatment of...
Gespeichert in:
Veröffentlicht in: | Cancer 2021-01, Vol.127 (1), p.12-26 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 26 |
---|---|
container_issue | 1 |
container_start_page | 12 |
container_title | Cancer |
container_volume | 127 |
creator | Hajdu, Steven I. |
description | During the period from 1942 to 1962, treatment attempts with single‐agent chemotherapy such as nitrogen mustard and urethan gained limited application. However, the groundbreaking success with aminopterin in the treatment of patients with pediatric acute leukemia and methotrexate in the treatment of gestational choriocarcinoma established single‐agent chemotherapy as a pioneering contribution to oncology. The landmark discovery that early‐stage Hodgkin disease is curable with radiation made radiotherapy into an essential specialty of oncology. Although radical surgical treatment dominated the field of surgery, the excision of localized cancers with or without adjuvant radiation emerged as new modality in therapy. Cytopathology and surgical pathology became new fields in medicine and pathologists became an integral part of the preoperative, intraoperative, and postoperative care of patients with cancer. The discovery of multiple new drugs demonstrated promising results and widened the field of oncology from the laboratory to the clinic. In the etiology of cancer, precancerous conditions were named and carcinoma of the lung was definitively linked to cigarette smoking. All things considered, the progress made between 1942 and 1962 came about through the dedicated work of many individuals. However, there were 7 distinguished pathfinders (2 pathologists, 1 pediatric pathologist–oncologist, 1 radiation therapist, 1 physician‐actuary, 1 gynecologist‐oncologist, and 1 chemist) who, despite their different backgrounds, interests, and sex, made groundbreaking contributions to oncology.
Over the 2 decades reviewed herein, advancements in radiotherapy and medical oncology coupled with the discovery of new chemotherapeutic drugs and the introduction of less radical surgical procedures were the most momentous events. The biographies of 7 individuals who contributed the most to the progress of oncology from 1942 to 1962 are presented. |
doi_str_mv | 10.1002/cncr.33223 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2454150178</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2454150178</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3933-7095d1f4036348e1e2c2202c9dabe39999233301fe903f6d2eecabbf49a02b9f3</originalsourceid><addsrcrecordid>eNp90c1KJDEQB_Agu-j4cfEBJLAXEVqTVPf05CiDuwqyK6LgrUmnKzOR7mRMupG--Qj7jPskm5lRD3vYXELIr_5UUoQcc3bOGRMX2ulwDiAE7JAJZ7LMGM_FFzJhjM2yIoenPbIf43M6lqKAXbIHwGQhOUzIcKf6pbGuwRCpddQ77Vu_GKkJvqP9EqmxIfZUt9ZZrVo6RKTe0GjdosU_b7_VAl26XmLnkw5qNdLebwqt64NvBt1b79Ylneo6v0hiOR6Sr0a1EY_e9wPy-P3qYX6d3f76cTO_vM00SICsTF023OQMppDPkKPQQjChZaNqBJmWgPQUblAyMNNGIGpV1yaXiolaGjggp9vcVfAvA8a-6mzU2LbKoR9iJfIi5wXj5SzRb__QZz8El7pLaiqZlLycJnW2VTr4GAOaahVsp8JYcVath1Gth1FthpHwyXvkUHfYfNKP30-Ab8GrbXH8T1Q1_zm_34b-BXm8lpI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2469099176</pqid></control><display><type>article</type><title>Pathfinders in oncology from the first clinical use of single‐agent chemotherapy to the introduction of mammography</title><source>MEDLINE</source><source>Wiley Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><source>Alma/SFX Local Collection</source><creator>Hajdu, Steven I.</creator><creatorcontrib>Hajdu, Steven I.</creatorcontrib><description>During the period from 1942 to 1962, treatment attempts with single‐agent chemotherapy such as nitrogen mustard and urethan gained limited application. However, the groundbreaking success with aminopterin in the treatment of patients with pediatric acute leukemia and methotrexate in the treatment of gestational choriocarcinoma established single‐agent chemotherapy as a pioneering contribution to oncology. The landmark discovery that early‐stage Hodgkin disease is curable with radiation made radiotherapy into an essential specialty of oncology. Although radical surgical treatment dominated the field of surgery, the excision of localized cancers with or without adjuvant radiation emerged as new modality in therapy. Cytopathology and surgical pathology became new fields in medicine and pathologists became an integral part of the preoperative, intraoperative, and postoperative care of patients with cancer. The discovery of multiple new drugs demonstrated promising results and widened the field of oncology from the laboratory to the clinic. In the etiology of cancer, precancerous conditions were named and carcinoma of the lung was definitively linked to cigarette smoking. All things considered, the progress made between 1942 and 1962 came about through the dedicated work of many individuals. However, there were 7 distinguished pathfinders (2 pathologists, 1 pediatric pathologist–oncologist, 1 radiation therapist, 1 physician‐actuary, 1 gynecologist‐oncologist, and 1 chemist) who, despite their different backgrounds, interests, and sex, made groundbreaking contributions to oncology.
Over the 2 decades reviewed herein, advancements in radiotherapy and medical oncology coupled with the discovery of new chemotherapeutic drugs and the introduction of less radical surgical procedures were the most momentous events. The biographies of 7 individuals who contributed the most to the progress of oncology from 1942 to 1962 are presented.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.33223</identifier><identifier>PMID: 33095913</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Aminopterin ; Arthur Purdy Stout ; Breast Neoplasms - drug therapy ; Breast Neoplasms - surgery ; Cancer ; Chemotherapy ; Choriocarcinoma ; Cigarette smoking ; Cytopathology ; Drug discovery ; Drug Therapy - methods ; Etiology ; Female ; Gertrude Belle Elion ; Health services ; history of cancer ; history of chemotherapy ; history of oncology ; history of radiology ; history of radiotherapy ; history of surgery ; history of surgical pathology ; history of tumor pathology ; Hodgkin's lymphoma ; Humans ; Lauren V. Ackerman ; Leukemia ; Lung carcinoma ; Mammography ; Mammography - methods ; Medical Oncology - methods ; Methotrexate ; Mildred Vera Peters ; Min Chiu Li ; Oncology ; Pathology ; Patients ; Pediatrics ; Radiation ; Radiation therapy ; Sidney Farber ; Surgery ; Urethan ; William Richard Doll</subject><ispartof>Cancer, 2021-01, Vol.127 (1), p.12-26</ispartof><rights>2020 American Cancer Society</rights><rights>2020 American Cancer Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3933-7095d1f4036348e1e2c2202c9dabe39999233301fe903f6d2eecabbf49a02b9f3</citedby><cites>FETCH-LOGICAL-c3933-7095d1f4036348e1e2c2202c9dabe39999233301fe903f6d2eecabbf49a02b9f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcncr.33223$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcncr.33223$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33095913$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hajdu, Steven I.</creatorcontrib><title>Pathfinders in oncology from the first clinical use of single‐agent chemotherapy to the introduction of mammography</title><title>Cancer</title><addtitle>Cancer</addtitle><description>During the period from 1942 to 1962, treatment attempts with single‐agent chemotherapy such as nitrogen mustard and urethan gained limited application. However, the groundbreaking success with aminopterin in the treatment of patients with pediatric acute leukemia and methotrexate in the treatment of gestational choriocarcinoma established single‐agent chemotherapy as a pioneering contribution to oncology. The landmark discovery that early‐stage Hodgkin disease is curable with radiation made radiotherapy into an essential specialty of oncology. Although radical surgical treatment dominated the field of surgery, the excision of localized cancers with or without adjuvant radiation emerged as new modality in therapy. Cytopathology and surgical pathology became new fields in medicine and pathologists became an integral part of the preoperative, intraoperative, and postoperative care of patients with cancer. The discovery of multiple new drugs demonstrated promising results and widened the field of oncology from the laboratory to the clinic. In the etiology of cancer, precancerous conditions were named and carcinoma of the lung was definitively linked to cigarette smoking. All things considered, the progress made between 1942 and 1962 came about through the dedicated work of many individuals. However, there were 7 distinguished pathfinders (2 pathologists, 1 pediatric pathologist–oncologist, 1 radiation therapist, 1 physician‐actuary, 1 gynecologist‐oncologist, and 1 chemist) who, despite their different backgrounds, interests, and sex, made groundbreaking contributions to oncology.
Over the 2 decades reviewed herein, advancements in radiotherapy and medical oncology coupled with the discovery of new chemotherapeutic drugs and the introduction of less radical surgical procedures were the most momentous events. The biographies of 7 individuals who contributed the most to the progress of oncology from 1942 to 1962 are presented.</description><subject>Aminopterin</subject><subject>Arthur Purdy Stout</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Breast Neoplasms - surgery</subject><subject>Cancer</subject><subject>Chemotherapy</subject><subject>Choriocarcinoma</subject><subject>Cigarette smoking</subject><subject>Cytopathology</subject><subject>Drug discovery</subject><subject>Drug Therapy - methods</subject><subject>Etiology</subject><subject>Female</subject><subject>Gertrude Belle Elion</subject><subject>Health services</subject><subject>history of cancer</subject><subject>history of chemotherapy</subject><subject>history of oncology</subject><subject>history of radiology</subject><subject>history of radiotherapy</subject><subject>history of surgery</subject><subject>history of surgical pathology</subject><subject>history of tumor pathology</subject><subject>Hodgkin's lymphoma</subject><subject>Humans</subject><subject>Lauren V. Ackerman</subject><subject>Leukemia</subject><subject>Lung carcinoma</subject><subject>Mammography</subject><subject>Mammography - methods</subject><subject>Medical Oncology - methods</subject><subject>Methotrexate</subject><subject>Mildred Vera Peters</subject><subject>Min Chiu Li</subject><subject>Oncology</subject><subject>Pathology</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Radiation</subject><subject>Radiation therapy</subject><subject>Sidney Farber</subject><subject>Surgery</subject><subject>Urethan</subject><subject>William Richard Doll</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90c1KJDEQB_Agu-j4cfEBJLAXEVqTVPf05CiDuwqyK6LgrUmnKzOR7mRMupG--Qj7jPskm5lRD3vYXELIr_5UUoQcc3bOGRMX2ulwDiAE7JAJZ7LMGM_FFzJhjM2yIoenPbIf43M6lqKAXbIHwGQhOUzIcKf6pbGuwRCpddQ77Vu_GKkJvqP9EqmxIfZUt9ZZrVo6RKTe0GjdosU_b7_VAl26XmLnkw5qNdLebwqt64NvBt1b79Ylneo6v0hiOR6Sr0a1EY_e9wPy-P3qYX6d3f76cTO_vM00SICsTF023OQMppDPkKPQQjChZaNqBJmWgPQUblAyMNNGIGpV1yaXiolaGjggp9vcVfAvA8a-6mzU2LbKoR9iJfIi5wXj5SzRb__QZz8El7pLaiqZlLycJnW2VTr4GAOaahVsp8JYcVath1Gth1FthpHwyXvkUHfYfNKP30-Ab8GrbXH8T1Q1_zm_34b-BXm8lpI</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Hajdu, Steven I.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20210101</creationdate><title>Pathfinders in oncology from the first clinical use of single‐agent chemotherapy to the introduction of mammography</title><author>Hajdu, Steven I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3933-7095d1f4036348e1e2c2202c9dabe39999233301fe903f6d2eecabbf49a02b9f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aminopterin</topic><topic>Arthur Purdy Stout</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Breast Neoplasms - surgery</topic><topic>Cancer</topic><topic>Chemotherapy</topic><topic>Choriocarcinoma</topic><topic>Cigarette smoking</topic><topic>Cytopathology</topic><topic>Drug discovery</topic><topic>Drug Therapy - methods</topic><topic>Etiology</topic><topic>Female</topic><topic>Gertrude Belle Elion</topic><topic>Health services</topic><topic>history of cancer</topic><topic>history of chemotherapy</topic><topic>history of oncology</topic><topic>history of radiology</topic><topic>history of radiotherapy</topic><topic>history of surgery</topic><topic>history of surgical pathology</topic><topic>history of tumor pathology</topic><topic>Hodgkin's lymphoma</topic><topic>Humans</topic><topic>Lauren V. Ackerman</topic><topic>Leukemia</topic><topic>Lung carcinoma</topic><topic>Mammography</topic><topic>Mammography - methods</topic><topic>Medical Oncology - methods</topic><topic>Methotrexate</topic><topic>Mildred Vera Peters</topic><topic>Min Chiu Li</topic><topic>Oncology</topic><topic>Pathology</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Radiation</topic><topic>Radiation therapy</topic><topic>Sidney Farber</topic><topic>Surgery</topic><topic>Urethan</topic><topic>William Richard Doll</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hajdu, Steven I.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hajdu, Steven I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pathfinders in oncology from the first clinical use of single‐agent chemotherapy to the introduction of mammography</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>127</volume><issue>1</issue><spage>12</spage><epage>26</epage><pages>12-26</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>During the period from 1942 to 1962, treatment attempts with single‐agent chemotherapy such as nitrogen mustard and urethan gained limited application. However, the groundbreaking success with aminopterin in the treatment of patients with pediatric acute leukemia and methotrexate in the treatment of gestational choriocarcinoma established single‐agent chemotherapy as a pioneering contribution to oncology. The landmark discovery that early‐stage Hodgkin disease is curable with radiation made radiotherapy into an essential specialty of oncology. Although radical surgical treatment dominated the field of surgery, the excision of localized cancers with or without adjuvant radiation emerged as new modality in therapy. Cytopathology and surgical pathology became new fields in medicine and pathologists became an integral part of the preoperative, intraoperative, and postoperative care of patients with cancer. The discovery of multiple new drugs demonstrated promising results and widened the field of oncology from the laboratory to the clinic. In the etiology of cancer, precancerous conditions were named and carcinoma of the lung was definitively linked to cigarette smoking. All things considered, the progress made between 1942 and 1962 came about through the dedicated work of many individuals. However, there were 7 distinguished pathfinders (2 pathologists, 1 pediatric pathologist–oncologist, 1 radiation therapist, 1 physician‐actuary, 1 gynecologist‐oncologist, and 1 chemist) who, despite their different backgrounds, interests, and sex, made groundbreaking contributions to oncology.
Over the 2 decades reviewed herein, advancements in radiotherapy and medical oncology coupled with the discovery of new chemotherapeutic drugs and the introduction of less radical surgical procedures were the most momentous events. The biographies of 7 individuals who contributed the most to the progress of oncology from 1942 to 1962 are presented.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>33095913</pmid><doi>10.1002/cncr.33223</doi><tpages>19</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-543X |
ispartof | Cancer, 2021-01, Vol.127 (1), p.12-26 |
issn | 0008-543X 1097-0142 |
language | eng |
recordid | cdi_proquest_miscellaneous_2454150178 |
source | MEDLINE; Wiley Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content; Alma/SFX Local Collection |
subjects | Aminopterin Arthur Purdy Stout Breast Neoplasms - drug therapy Breast Neoplasms - surgery Cancer Chemotherapy Choriocarcinoma Cigarette smoking Cytopathology Drug discovery Drug Therapy - methods Etiology Female Gertrude Belle Elion Health services history of cancer history of chemotherapy history of oncology history of radiology history of radiotherapy history of surgery history of surgical pathology history of tumor pathology Hodgkin's lymphoma Humans Lauren V. Ackerman Leukemia Lung carcinoma Mammography Mammography - methods Medical Oncology - methods Methotrexate Mildred Vera Peters Min Chiu Li Oncology Pathology Patients Pediatrics Radiation Radiation therapy Sidney Farber Surgery Urethan William Richard Doll |
title | Pathfinders in oncology from the first clinical use of single‐agent chemotherapy to the introduction of mammography |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T09%3A48%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pathfinders%20in%20oncology%20from%20the%20first%20clinical%20use%20of%20single%E2%80%90agent%20chemotherapy%20to%20the%20introduction%20of%20mammography&rft.jtitle=Cancer&rft.au=Hajdu,%20Steven%20I.&rft.date=2021-01-01&rft.volume=127&rft.issue=1&rft.spage=12&rft.epage=26&rft.pages=12-26&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.33223&rft_dat=%3Cproquest_cross%3E2454150178%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2469099176&rft_id=info:pmid/33095913&rfr_iscdi=true |